sickle cell disease

Pharmalot By Ed Silverman

Amgen joins a growing list of drug makers cutting discounts to safety-net hospitals

Breaking News By Andrew Joseph

First case of Omicron coronavirus variant identified in the U.S.

Pharmalot By Ed Silverman

Pharmalittle: Merck Covid pill squeaks past FDA panel; analysis explores whether insurers give ‘fair access’ to drugs

Pharmalot By Ed Silverman

Just how many barriers do health insurers create to fair access to medicines?

Biotech By Adam Feuerstein

In a medical first, Vertex drug successfully targets the underlying cause of a genetic kidney disease

Pharmalot By Ed Silverman

Socially responsible investor coalitions push greater access to medicines in shareholder proposals

First Opinion Podcast By Patrick Skerrett

Listen: Who owns your health data — and why you should care

First Opinion By Rachel Vreeman

Losing Faith: Reflecting on 40 years of the HIV pandemic